SCHEMBL20021170

SCHEMBL20021170

CCc1c(C)cc2nc(NCCN3CCOCC3)ccc2c1-c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.51
ALDH1A1 P00352 7/20 0.50
HSD17B10 Q99714 6/20 0.50
USP2 O75604 3/20 0.50
HPGD P15428 2/20 0.50
MAPT P10636 5/20 0.47
TSHR P16473 3/20 0.47
MAPK1 P28482 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP1A2 P05177 5/20 0.44
CYP3A4 P08684 5/20 0.44
CYP2D6 P10635 5/20 0.44
CLK4 Q9HAZ1 4/20 0.44
CYP2C19 P33261 3/20 0.44
HIF1A Q16665 1/20 0.44
LMNA P02545 4/20 0.43
KDM4E B2RXH2 2/20 0.43
CHRM1 P11229 1/20 0.43
ALOX15 P16050 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3326729 0.89 ACHE (0.47) ACHEALDH1A1HSD17B10USP2HPGD
SCHEMBL20021083 0.79 KMT2A (0.51) ALDH1A1HSD17B10HPGDTSHRMAPK1
SCHEMBL15182623 0.79 ACHE (0.43) ACHEALDH1A1HSD17B10USP2HPGD
SCHEMBL27910428 0.79 ALDH1A1 (0.41) ACHEALDH1A1HSD17B10USP2HPGD
SCHEMBL245545 0.78 ACHE (0.42) ACHEALDH1A1HSD17B10USP2HPGD
SCHEMBL27928087 0.73 POLB (0.45) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL11800152 0.69 MAPT (0.60) ACHEALDH1A1HSD17B10USP2HPGD
SCHEMBL20021050 0.69 KMT2A (0.48) ALDH1A1HSD17B10USP2HPGDTSHR
SCHEMBL8691758 0.68 CHRM1 (0.63) ACHEALDH1A1HSD17B10USP2HPGD
SCHEMBL3303958 0.68 KMT2A (0.49) ALDH1A1HSD17B10USP2HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588455-B1 2-QUINOLINYL-ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS GILEAD SCIENCES INC (US) 2018-04-04 EP disclosed